ADSTILADRIN
NDC 55566-1050 · Ferring Pharmaceuticals Inc.
Generic namenadofaragene firadenovec-vncg
Dosage formSUSPENSION
RouteINTRAVESICAL
Active ingredient(s)NADOFARAGENE FIRADENOVEC
Strength300000000000 {VP}/mL
Marketing categoryBLA
Packages
55566-1050-1 — 4 VIAL in 1 CARTON (55566-1050-1) / 20 mL in 1 VIAL (55566-1050-0)
55566-1050-2 — 20 mL in 1 VIAL (55566-1050-2)
Billed under HCPCS
J9029 — Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose Medicare Part B payment limit (ASP + 6%): $64331.61